AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Recordati Industria Chimica e Farmaceutica

AGM Information May 5, 2021

4056_rns_2021-05-05_5e1aae1e-bd18-4c34-b0ce-107b58be27fb.pdf

AGM Information

Open in Viewer

Opens in native device viewer

RECORDATI: PUBLIC DISCLOSURE (MINUTES OF THE ORDINARY GENERAL MEETING OF THE SHAREHOLDERS 20.04.2021)

Milan, 5 th May 2021 – Please be informed that as of today, pursuant to Article 125-quater of the Legislative Decree 58/98, the minutes of the Ordinary General Meeting of the Shareholders held on 20th April 2021 are available to the public at the Company's registered office, on the Company's website (www.recordati.it, in the area "Investors", section "Shareholders' Meetings") and on the storage mechanism ().

Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in Europe, Russia and the other C.I.S. countries, Ukraine, Turkey, North Africa, the United States of America, Canada, Mexico, some South American countries, Japan and Australia. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in several therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases. Consolidated revenue for 2020 was € 1,448.9 million, operating income was € 469.0 million and net income was € 355.0 million.

For further information:

Recordati website: www.recordati.com

Investor Relations Media Relations Federica De Medici Studio Noris Morano (39) 02 48787146 (39) 02 76004736, (39) 02 76004745

e-mail: [email protected] e-mail: [email protected]

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.

Registered Office Via Matteo Civitali, 1 20148 Milano, Italy Ph. (39) 02 487871 Fax (39) 02 40073747 www.recordati.com

Share Capital € 26.140.644,50 fully paid-up Milano, Monza, Brianza and Lodi Comp. Reg. No. 00748210150 Tax Code/VAT No. 00748210150 Milano R.E.A. No. 401832

Company subject to the Management and Coordination Activity of Rossini Luxembourg S.àr.l

Talk to a Data Expert

Have a question? We'll get back to you promptly.